Tumor News and Research

RSS

New technology shows encouraging results for treating osteosarcoma

A preclinical study led by researchers at The University of Texas MD Anderson Cancer Center shows an antibody-drug conjugate (ADC) targeting surface protein MT1-MMP can act as a guided missile in eradicating osteosarcoma tumor cells without damaging normal tissues.

13 Apr 2021

Low health literacy may discourage men from selecting active surveillance for prostate cancer

Tumor gene profiling is a tool that can help patients with a cancer diagnosis make informed decisions about treatment.

13 Apr 2021

Research could lead to better treatment for aggressive prostate cancer

New research from CU Cancer Center member Scott Cramer, PhD, and his colleagues could help in the treatment of men with certain aggressive types of prostate cancer.

12 Apr 2021

Exercise training may slow breast cancer growth by increasing anti-tumor immune response

Exercise training may slow tumor growth and improve outcomes for females with breast cancer - especially those treated with immunotherapy drugs - by stimulating naturally occurring immune mechanisms, researchers at Massachusetts General Hospital and Harvard Medical School have found.

12 Apr 2021

Yale researchers provide new insights into acquired resistance to cancer immunotherapy

New research by Yale Cancer Center shows insights into modeling resistance to immune checkpoint inhibitors, a form of cancer immunotherapy.

12 Apr 2021

Research may lead to a significant breakthrough in the battle against deadly brain tumors

Groundbreaking research from Tel Aviv University may lead to a significant breakthrough in the battle against deadly brain cancer.

12 Apr 2021

Novel immunotherapy approach may offer therapeutic advantages for melanoma

In a new study led by Yale Cancer Center, researchers have advanced a tumor-targeting and cell penetrating antibody that can deliver payloads to stimulate an immune response to help treat melanoma.

12 Apr 2021

Researchers work to develop dual antigen COVID-19 vaccine candidate

A new study has been published on the medRxiv* preprint server, which focuses on the development of a dual-antigen COVID-19' T cell' vaccine. This vaccine is developed based on the expression of both S protein and nucleocapsid (N) protein of SARS-CoV-2, using a next-generation human adenovirus serotype 5 (Ad5) platform.

12 Apr 2021

Could N protein-based COVID-19 vaccines hinder SARS-CoV-2's NK cell inhibition?

Upon SARS-CoV-2 infection, what are the changes occurring on the surface of the host cell? To address this, and a team of researchers undertook a study exploring the natural killer (NK) cells and their role during a SARS-CoV-2 infection.

12 Apr 2021

CD40 drug before surgery can benefit patients with early-stage pancreatic cancer

Giving early-stage pancreatic cancer patients a CD40 immune-stimulating drug helped jumpstart a T cell attack to the notoriously stubborn tumor microenvironment before surgery and other treatments, according to a new study from researchers in the Abramson Cancer Center (ACC) at the University of Pennsylvania.

12 Apr 2021

Study reveals new insights into the effects of chemotherapy on tumor microenvironment

Research from Queen Mary University of London has revealed novel insights into the effects of chemotherapy on the tumor microenvironment (TME).

12 Apr 2021

Mutant KRAS and P53 promote growth and metastasis of pancreatic cancer

Researchers at The University of Texas MD Anderson Cancer Center have discovered that mutant KRAS and p53, the most frequently mutated genes in pancreatic cancer, interact through the CREB1 protein to promote metastasis and tumor growth.

12 Apr 2021

Aneuploidy testing can be key in determining optimal treatment for lung cancer patients

Patients with non-small cell lung cancer (NSCLC) whose cancer cells have low levels of aneuploidy - an abnormal number of chromosomes - tend to respond better to immune checkpoint inhibitor drugs than patients with higher levels, Dana-Farber Cancer Institute researchers will report at the virtual AACR Annual Meeting 2021.

12 Apr 2021

FDA approves marketing of first AI-based device to assist clinicians during colon cancer screening

Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.

9 Apr 2021

Tumor News and Research

New technology shows encouraging results for treating osteosarcoma

Low health literacy may discourage men from selecting active surveillance for prostate cancer

Research could lead to better treatment for aggressive prostate cancer

Exercise training may slow breast cancer growth by increasing anti-tumor immune response

Yale researchers provide new insights into acquired resistance to cancer immunotherapy

Research may lead to a significant breakthrough in the battle against deadly brain tumors

Novel immunotherapy approach may offer therapeutic advantages for melanoma

Researchers work to develop dual antigen COVID-19 vaccine candidate

Could N protein-based COVID-19 vaccines hinder SARS-CoV-2's NK cell inhibition?

CD40 drug before surgery can benefit patients with early-stage pancreatic cancer

Study reveals new insights into the effects of chemotherapy on tumor microenvironment

Mutant KRAS and P53 promote growth and metastasis of pancreatic cancer

Aneuploidy testing can be key in determining optimal treatment for lung cancer patients

FDA approves marketing of first AI-based device to assist clinicians during colon cancer screening

Gift boosts efforts to understand and combat rare cancers

Study aims to advance breast cancer detection methodologies through spectroscopic imaging

Study shows how melanoma cells evade detection and destruction by immune cells

Mitochondrial DNA mutations can reduce death risk in people with bowel cancer

Real-time imaging shines light on the coordination of neural stem cell activation

IRB Barcelona researchers find the Achilles heel of some lung tumors

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News